DAVID CUMMINGS: Open Payments
NPI 1811466014 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,197 in 178 payments from 27 companies in 2025. Trend: 2023 $2,181 · 2024 $2,306 · 2025 $3,197
Food & beverage: $3,097Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $655 |
| AstraZeneca Pharmaceuticals LP | 13 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $244 |
| Lilly USA, LLC | 12 | $198 |
| Dexcom, Inc. | 19 | $185 |
| Exact Sciences Corporation | 7 | $177 |
| PFIZER INC. | 10 | $160 |
| Otsuka America Pharmaceutical, Inc. | 7 | $155 |
| Amgen Inc. | 8 | $148 |
| Astellas Pharma US Inc | 2 | $125 |
Products named: VRAYLAR, CAPLYTA, AIRSUPRA, QULIPTA, Dexcom G6 Transmitter, Cologuard Collection Kit, REXULTI, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
